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ABSTRACT
Mesenchymal stem cells (MSCs) are crucial for tissue homeostasis and regeneration. Though of
prime interest, their potentially protective role on neutrophil-induced tissue damage, associated
with high morbidity and mortality, has not been explored in sufficient detail. Here we report
the therapeutic skill of MSCs to suppress unrestrained neutrophil activation and to attenuate
severe tissue damage in a murine immune-complex mediated vasculitis model of unbalanced
neutrophil activation. MSC-mediated neutrophil suppression was due to intercellular adhesion
molecule 1-dependent engulfment of neutrophils by MSCs, decreasing overall neutrophil num-
bers. Similar to MSCs in their endogenous niche of murine and human vasculitis, therapeutically
injected MSCs via upregulation of the extracellular superoxide dismutase (SOD3), reduced super-
oxide anion concentrations and consequently prevented neutrophil death, neutrophil extracellu-
lar trap formation and spillage of matrix degrading neutrophil elastase, gelatinase and
myeloperoxidase. SOD3-silenced MSCs did not exert tissue protective effects. Thus, MSCs hold
substantial therapeutic promise to counteract tissue damage in conditions with unrestrained
neutrophil activation. STEM CELLS 2016;34:2393–2406
SIGNIFICANCE STATEMENT
We have identified a multilayered strategy of mesenchymal stem cells to suppress tissue dam-
age mediated by overactivated neutrophils via intercellular adhesion molecule 1 mediated
engulfment of neutrophils and an adaptive release of superoxide dismutase 3 dampening
enhanced reactive oxygen species level and in consequence suppress neutrophil extracellular
trap formation, neutrophil death, and excessive spillage of tissue damaging proteases.
INTRODUCTION
Neutrophils constitute the largest, evolutionary
conserved fraction of circulating leukocytes.
They are responsible for the first line of defense
against pathogens relying on a plethora of anti-
microbial mechanisms, all enacted during the
process of neutrophil activation. Neutrophil
activation generates high concentrations of anti-
microbial reactive oxygen species (ROS) with
superoxide anions (O22 ) as the major compo-
nent [1, 2] to create an environment that is toxic
for pathogens. In addition, high ROS concentra-
tions are responsible for the release and activa-
tion of neutrophil-derived proteases[3, 4], and
the formation of neutrophil extracellular traps
(NETs) with expulsion of chromatin fibers from
the nucleus of neutrophils as additional strat-
egies to effectively combat and kill invading
microorganisms [5]. However, when these
mechanisms become overactivated either by
persisting stimuli or by impeded resolution,
they turn out to be highly destructive for the
surrounding tissues and may cause severe dam-
age and tissue break down as observed in neu-
trophil dominated diseases. Examples of such
“inflammasomopathies” with enhanced release
of neutrophil activating interleukin (IL)21b are
pyoderma gangrenosum [6], immune complex
(IC)-mediated vasculitis [7] occurring in systemic
lupus erythematosus [8] as well as conditions
with enhanced release of neutrophil activating
danger signals as in trauma and chronic non-
healing wounds [9]. Earlier studies further sug-
gest that persistent neutrophil activation is at
least in part responsible for malignant transfor-
mation observed at high frequency in chroni-
cally inflamed tissue [10]. Diseases due to
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uncontrolled neutrophil activation are still difficult-to-treat and
based on their tissue and organ destructive nature reveal high
morbidity and mortality. Hence, with the current lack of effi-
cious treatments in therapy refractory cases, an urgent need
exists to develop new therapeutic strategies.
Tissue homeostasis and regeneration critically depend on
self-renewal and the precise control of inflammation by the
plasticity and adaptive responsiveness of mesenchymal stem
cells (MSCs) [11]. MSCs are endowed with the unique
capacity to sense inflammatory cues in their environment. In
the absence of danger signals, MSCs actively coordinate the
resolution of inflammation, a program which most likely has
evolved to protect their own DNA from deleterious ROS
attacks to guarantee a reliable blue print for self-renewal and
replenishment of lost somatic cells essentially required for tis-
sue homeostasis.
MSCs exert a variety of immune-regulatory functions on
cells of both adaptive and innate immunity. These include
suppression of effector T cell proliferation and function with
concomitant induction of their apoptosis [12, 13], enhanced
generation of regulatory T cells [14, 15], inhibition of B cell
activation and proliferation [16], suppression of differentia-
tion, maturation and antigen presentation of dendritic cells
[17], inhibition of proliferation and cytotoxicity of natural
killer cells [18], and induction of a shift from pro-
inflammatory M1 to anti-inflammatory M2 macrophages
[19–21]. Though of prime relevance, the interactions between
MSCs and neutrophils—while addressed in the unperturbed
bone marrow stem cell niche [22], vessels [23], and in brain
ischemia [24]—have not been explored in sufficient mechanis-
tic details in tissue damage owing to unrestrained neutrophil
activation under in vivo conditions of murine and human
vasculitis.
In this study, we investigate the interactions between
MSCs and neutrophils with particular focus on the potential
protective effects of MSCs on neutrophil induced tissue dam-
age, which would be exploitable for MSC-based therapies.
MATERIALS AND METHODS
Mice and Human Samples
All animal experiments were conducted in accordance with
protocols approved by the Institutional Review Board (IRB)
and the Ethical Committee at the University of Ulm. For
experiments using human skin samples or primary human
cells, informed consent for the studies was obtained from the
patients in accordance with the Declaration of Helsinki and
IRB approval of University of Ulm. The details are presented
in Supporting Information Experimental Procedures.
Isolation of Neutrophils
Human peripheral neutrophils (hNeu) were isolated from
buffy coats (German Red Cross, Ulm, Germany, www.drk-ulm.
de) using gradient centrifugation. Murine bone marrow neu-
trophils (mNeu) were isolated by immunomagnetic separation
using the negative depletion method with mouse neutrophil
isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany,
http://www.miltenyibiotec.com). The details are presented in
Supporting Information Experimental Procedures.
Flow Cytometry
Flow cytometry was performed on a FACS Canto II (BD Bio-
sciences, San Jose, CA, http://www.bdbiosciences.com/) with
FACSDiva software for data acquisition. Data were analyzed
with Summit software v4.3 (Beckman Coulter, Brea, Califor-
nia, www.beckmancoulter.com).
Oxidative Burst Assay
Neutrophils were cultured alone or cocultured with AT-MSCs
at indicated neutrophil:MSC ratios for 4 hours. Thereafter,
neutrophils were activated by 100 ng/ml phorbol 12-myristate
13-acetate (PMA) (Sigma-Aldrich, St. Louis, MO, http://www.
sigmaaldrich.com) at 378C for 10 minutes. Neutrophils treated
with DMSO served as non-activated controls. Cocultures were
labeled with the redox sensitive dye dihydrorhodamine 123
(DHR) (Life Technologies, Carlsbad, CA, www.lifetechnologies.
com) at 5 mM at 378C for 30 minutes. The cells were put on
ice to stop the reaction, washed with phosphate-buffered
saline (PBS) and subjected to flow cytometric analysis.
Unstained cells served as background control. The intensity of
DHR dye was analyzed within the neutrophil gate.
Quantification of NET Formation
The immunostaining of extracellular chromatin fiber with anti-
DNA/histone 1 antibody (Merck Millipore, Darmstadt, Ger-
many, www.emdmillipore.com) was used to demonstrate the
NET formation. The fluorescence intensity of Sytox orange
nucleic acid stain (Life Technologies) was used to quantify the
NET measured with Mithras LB940 microplate reader (Bert-
hold Technologies, Bad Wildbad, Germany, https://www.bert-
hold.com/), at excitation and emission wavelengths of 540 nm
and 580 nm, respectively. The details are presented in Sup-
porting Information Experimental Procedures.
Phagocytosis Assay
AT-MSCs were labeled with 2.5 mM carboxyfluorescein succini-
midyl ester (CFSE) (Life Technologies). MACS purified mNeu
were labeled with 2 mM PKH26 (Sigma-Aldrich) and cultured
at 378C overnight to induce apoptosis. Thereafter, apoptotic
mNeu were cocultured with AT-MSCs or macrophages at a
mNeu:MSC (or macrophages) ratio of 10:1 for 24 hours in
Lab-Tek II chamber slides (NUNC, Roskilde, Denmark, www.
thermofisher.com/). The slides were fixed and examined with
Zeiss LSM710 confocal microscope and ZEN2010 software
(Carl Zeiss, Oberkochen, Germany, www.zeiss.com). The pin-
hole was set to achieve 1 mm light section. In another set of
experiments, the cocultures were harvested after 24 hours
and analyzed by flow cytometry.
Arthus Reaction in Mouse Skin
2.5 x 105 AT-MSCs in 100 ml PBS per injection were intrader-
mally injected to the both sides of shaved dorsal skin of mice.
Mice intradermally injected with 100 ml PBS served as con-
trols. To induce IC-mediated vasculitis, mice were challenged
with the Arthus reaction [25, 26]. Briefly, the Arthus reaction
was elicited by i.v. injection of 100 ml of 2% bovine serum
albumin (BSA) and 1% Evans blue (Sigma-Aldrich) in PBS.
Afterward 40 ml of rabbit anti-BSA antibody (Sigma-Aldrich) at
the concentration of 4.8 mg/ml was injected intradermally
into the dorsal skin that had been injected with AT-MSCs or
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PBS. Rabbit IgG served as the background control. Mice were
sacrificed 4 hours after the Arthus reaction and skin specimen
were harvested and digitally photographed. The areas of
Evans blue spots on the skin, representing the areas of hem-
orrhage due to IC-mediated vasculitis, were analyzed by
Image J.
Small Interfering RNA Transfection
AT-MSCs were transfected with human SOD3 small interfering
RNA (siRNAs) or control siRNA (Qiagen, Hilden, Germany,
https://www.qiagen.com) at a final concentration of 30 nM
using Lipofectamine RNAiMAX (Life Technologies). Cells were
harvested 48 hours after transfection for SOD3 mRNA and
protein expression analysis, or for injection or coculture with
neutrophils. The details are presented in Supporting Informa-
tion Experimental Procedures.
Statistics
Two-tailed unpaired Student’s t tests or Mann–Whitney tests,
as indicated in figure legends, were used to determine statis-
tical significance.
RESULTS
MSCs Suppress Oxidative Burst-Induced Neutrophil
Death and Peroxidase/Protease Spillage
Activation of the NADPH oxidase with enhanced release of
antimicrobial ROS to pathogen containing phagosomes ini-
tiates an apoptotic program in activated neutrophils which
allows to prevent uncontrolled spillage of their tissue toxic
cargo [27]. By contrast, unrestrained neutrophil activation
with high ROS concentrations results in active degranulation
and neutrophil death with the induction of leaky plasma
membrane and an uncontrolled release of several proteases
with specificity for vessel wall and interstitial connective tis-
sue components eventually leading to vascular tissue break
down. As unrestrained high ROS concentrations with pro-
longed oxidative burst are responsible for this vicious
sequence of events, we first set out to explore the effect of
fully characterized human adipose tissue derived mesenchy-
mal stem cells (MSCs) (Supporting Information Fig. S1A–S1G)
on the suppression of high ROS release from activated neutro-
phils. Following a 4 hours coculture of MSCs and untouched
mNeu from C57BL/6 mice with a reproducible purity of 99%
(Supporting Information Fig. S1H), PMA-induced oxidative
burst was measured by flow cytometry with the ROS indicator
dye DHR. The majority (80.5%) of PMA-treated mNeu revealed
a DHR bright staining indicating that most of the mNeu had
undergone oxidative burst, while DMSO-treated control mNeu
were DHR negative. Of note, the percentage of ROS producing
mNeu was reduced to 73.5% at a mNeu:MSC ratio of 100:1,
and further to 42.2% at a mNeu:MSC ratio of 10:1 (Fig. 1A).
This indicates that MSCs in a concentration-dependent man-
ner could robustly reduce neutrophil oxidative burst. This was
further explored in vivo in a murine model of PMA-induced
dermatitis [28]. Intradermal injection of PMA induced recruit-
ment (Supporting Information Fig. S2A) and activation of neu-
trophils with enhanced oxidative burst as assessed by whole
body in vivo imaging with the ROS sensitive chemiluminescent
probe L-012 [29] (Supporting Information Fig. S2B). By con-
trast, elevated ROS levels were not observed in CD18 (the
common b chain of b2 integrins)-deficient mice (Supporting
Information Fig. S2A, S2B), indicating that PMA-induced der-
matitis is due to ROS releasing neutrophils as CD18 is essen-
tial for the emigration of neutrophils from the vessel into the
skin with subsequent ROS production [30]. Importantly, simi-
lar to the in vitro data, injection of MSCs at the site of PMA-
induced dermatitis significantly dampened the unrestrained
oxidative burst in vivo (Supporting Information Fig. S2C, S2D).
In case that unrestrained oxidative burst is responsible for
neutrophil death and degranulation, we would expect that
MSCs exert a protective role on the death rate and the
release of toxic proteases from neutrophils by reducing ROS
concentrations. After a 24 hours incubation period, mNeu
death was analyzed by Annexin V and PI staining using flow
cytometry. Out of 2 x 106 PMA-stimulated mNeu which were
cultured in the absence of MSCs, 66.1% stained positive for
Annexin V, while the number of dead mNeu were reduced to
59.5%, 44.7%, and 15.9%, respectively, when the same num-
ber of activated mNeu were cocultured with 2 x 103, 2 x 104,
and 2 x 105 MSCs, respectively, (Fig. 1B, 1C). These data indi-
cate that MSCs inhibit neutrophil death. Similar effects were
observed in cocultures of MSC with PMA-stimulated hNeu iso-
lated from buffy coats of healthy donors (Supporting Informa-
tion Figs. S1I, S3A–S3C). These results indicate that there was
no apparent species difference between human and murine
cells in regard to MSC-neutrophil interactions, suggesting trac-
table murine models to be particularly suited to study these
interactions in vivo.
Interestingly, when PMA-activated mNeu were cocultured
with MSCs, the concentration and the activity of neutrophil
released myeloperoxidase (MPO) was significantly reduced in
supernatants (Fig. 1D, 1E). Similarly, only in the presence of
MSCs, the release and the activity of neutrophil gelatinase (also
known as matrix metalloproteinase-9, MMP-9) and neutrophil
elastase (NE), both responsible for extracellular matrix break
down, were significantly reduced (Fig. 1F–1H). Our data support
the notion that MSCs are able to protect from the consequences
of unrestrained oxidative burst reducing overall neutrophil
death and associated spillage of their toxic cargo in vitro.
MSCs Reduce Neutrophil Extracellular Trap Formation
and Engulf Neutrophils
NETs have been identified as a new powerful antimicrobial
weapon of neutrophils [5]. Microorganisms are trapped within
the expulsed nucleic chromatin and subsequently are killed by
highly concentrated, NET-entangled antimicrobial proteins as
well as MPO [31] and NE [32]. Immunostaining with an antibody
against DNA/histone1 complexes showed massive fiber-like NET
structures around hNeu activated with PMA. In contrast, when
cocultured with MSCs, significantly less NETs were observed in
PMA-stimulated hNeu. For comparison, human dermal fibro-
blasts did not reveal any inhibitory effect on NET formation
when cocultured with activated hNeu (Fig. 2A). Quantification
of NET formation by Sytox orange, a noncell-permeable DNA
specific dye staining extracellular NETs [33, 34], revealed a signif-
icant increase in Sytox orange fluorescence intensity of PMA-
activated hNeu compared to low intensities of DMSO-treated
control hNeu. Coculture of activated hNeu with increasing cell
numbers of MSCs resulted in a concentration-dependent reduc-
tion of NET formation. Notably, NET formation was reduced by
Jiang, Muschhammer, Qi et al. 2395
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Figure 1. MSCs suppress oxidative burst, death, peroxidase and proteases release. 2 x 106 mNeu per well were cultured alone or
cocultured with AT-MSCs at mNeu:MSC ratios of 10:1, 100:1, and 1000:1. (A): 4 hours after coculture, mNeu were activated by 100 ng/
ml PMA at 378C for 10 minutes. mNeu treated with DMSO served as nonactivated control. Cocultures were labeled with 5 mM dihydro-
rhodamine 123 (DHR) and APC-conjugated Gr-1 antibody at 378C for 30 minutes, and subjected to flow cytometric analysis. DHR inten-
sity was analyzed within the Gr-11 gate. The depicted histograms are representative of three independent experiments. (B): Cocultures
were harvested 24 hours later, and labeled with Annexin V-FITC, PI, and Gr-1-APC, and analyzed by flow cytometry. The depicted dot
plots and histograms were gated on Gr-11 population, and are representative of three independent experiments. (C): Depicted are per-
centages of Annexin V1 cells expressed as mean6 SEM of three independent experiments. ***, p< .001. (D–H): Four hours after cocul-
ture, mNeu were activated by 100 ng/ml PMA for 30 minutes. Supernatants from cocultures were harvested. (D) MPO concentrations
were measured by ELISA. (E) The MPO activity was assessed using the TMB substrate based activity assay in a 10 minute interval. (F–G)
Total and active neutrophil gelatinase (MMP-9) was evaluated based on its proteolytic activity of converting a pro-detecting enzyme to
an active-detecting enzyme, which converts peptide substrate into colored product. The proMMP-9 in the supernatants was activated
by p-aminophenyl mercuric acetate. (H) NE concentrations were calculated from its proteolytic activity of converting a nonfluorescent
substrate to a fluorescent product. *, p< .05; **, p< .01; ***, p< .001 by Student’s t tests. These experiments were independently
repeated three times with similar results. Abbreviations: MPO, myeloperoxidase; mNeu, murine bone marrow neutrophils; MSCs, mesen-
chymal stem cells; NE, neutrophil elastase, TMB, 3,30,5,50-Tetramethylbenzidine.
Figure 2. MSCs reduce NETs formation and engulf neutrophils. (A): 2 x 105 hNeu were cultured alone or cocultured with 2 x 104 AT-MSCs or
HDF in wells of glass chamber slides and activated by 100 ng/ml PMA for 3 hours. Slides were fixed and labeled with anti-DNA/histone-1 fol-
lowed by AF555-conjugated anti-mouse IgG (red) and counterstained with DAPI (blue). Scale bar: 200 mm. (B): 1 x 105 hNeu were cultured alone
or with AT-MSCs at hNeu:MSC ratios of 10:1, 100:1 and 1000:1 and subsequently activated with 100 ng/ml PMA for 3 hours. Cocultures were
labeled with 0.25 mM Sytox orange for 5 minutes at room temperature and fluorescence intensities were measured by microplate reader. Cul-
ture medium containing Sytox orange served as background fluorescent control. Fluorescence intensities were normalized on the intensity of
non-activated controls. Results are expressed as mean6 SD of five-plicate measurements. This experiment was independently repeated three
times with similar results. ***, p< .001. (C–D): 1x106 mNeu were labeled with 2 mM PKH26 and cultured at 378C overnight to induce apoptosis.
Thereafter, mNeu were cocultured with 1x105 of 2.5 mM CFSE labeled AT-MSCs or murine bone marrow derived macrophages for 24 hours. (C)
Cocultured cells were fixed on chamber slides and photographed under confocal microscope with 1 mm light section. White scale bar: 50 mm;
yellow scale bar: 10 mm. The squares in the “Merge” panel indicate the areas enlarged in the “Enlarge” panel. (D) Cocultures were analyzed by
flow cytometry. AT-MSCs or macrophages cocultured with PKH26 labeled mNeu are depicted in filled grey histograms, and the counterparts
cocultured with nonlabeled mNeu are shown in empty histograms. The depicted photographs and histograms are representative of three inde-
pendent experiments. M/, macrophages. (E): AT-MSCs were cultured alone or with PMA activated mNeu at a mNeu:MSCs ratio of 10:1. 24
hours after culture, cells were labeled with CD73-APC and ICAM-1-PE or VCAM-1-PE antibodies and subjected to flow cytometric analysis. The
ICAM-1 and VCAM-1 expression were analyzed in CD731 MSC gate. (F–G): CFSE labeled MSCs (green) were cocultured with PKH26 labeled
mNeu (red) from wild-type (CD181/1) or CD182/2 mice at a mNeu:MSC ratio of 10:1 for 24 hours. The engulfment of neutrophils by MSCs
were examined by (F) confocal microscopy, white scale bar: 50 mm; yellow scale bar: 10 mm or (G) flow cytometry. Abbreviations: AU, arbitrary
unit. HDF, human dermal fibroblasts; ICAM-1, intercellular adhesion molecule 1; hNeu, human peripheral neutrophils; MSCs, mesenchymal
stem cells; mNeu, murine bone marrow neutrophils; NETs, neutrophil extracellular traps; RFI, relative fluorescence intensity.
63.5%, when hNeu were cocultured at a hNeu:MSC ratio of 10:1
(Fig. 2B).When MSCs were cocultured with mNeu, a similar sup-
pressive effect on NET formation was observed (Supporting
Information Fig. S3D–S3E).
Macrophage-mediated phagocytosis of activated neutro-
phils constitutes an effective measure to terminate or limit
unrestrained neutrophil activation and to prevent spillage of tis-
sue toxic ingredients from neutrophils. To examine a possible
physical interaction between neutrophils and MSCs, mNeu were
labeled with the red fluorescent dye PKH26 and cocultured with
green fluorescent CFSE-labeled MSCs for 24 hours. CFSE-labeled
murine bone marrow macrophages served as a control for pro-
fessional phagocytes. Surprisingly, MSCs were found to engulf
neutrophils in cocultures. The majority of MSCs display intracel-
lular vesicles containing neutrophils after 24 hours of coculture
as depicted in the merged and enlarged confocal images (Fig.
2C). The possibility that neutrophils simply attached to MSCs
can be reliably excluded as the light section of confocal micros-
copy was set at 1 mm. However, compared to professional phag-
ocytes that can degrade engulfed neutrophils in
phagolysosomes indicated by a more evenly distributed yellow
fluorescence, MSCs did not have such capacity and their cargos
of engulfed neutrophils apparently remained within vesicles
(Fig. 2C). These observations were in line with results from flow
cytometric analysis. Nearly half of the MSCs (46.8%) were
PKH26 positive, indicative of engulfed neutrophils, while almost
all macrophages (93.4%) were positive for PKH26 and displayed
elevated fluorescent intensity (Fig. 2D).
Figure 2. Continued.
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Juxtacrine cellular contacts between neutrophils and vas-
cular cells are predominantly mediated by b2-integrin-ICAM-1
and b1-integrin-vascular cell adhesion molecule 1 (VCAM-1)
interactions [30, 35]. While untreated MSCs constitutively
expressed low levels of ICAM-1 and VCAM-1, the expression
of ICAM-1 but not of VCAM-1 was substantially upregulated
on MSCs in coculture with activated mNeu (Fig. 2E). More-
over, the engulfment of neutrophils by MSCs was significantly
reduced when MSCs were cocultured with CD182/2 mNeu
lacking b2 integrins (Fig. 2F, 2G). These data indicate that
MSCs, in addition to reducing ROS release suppressing of NET
formation, adopted an independent strategy of ICAM-1-
mediated neutrophil engulfment to prevent further tissue
damage.
MSCs Reduce Vessel Destruction and Hemorrhage in
Immune Complex-Mediated Vasculitis
We next explored neutrophil overactivation and subsequent
tissue damage in human IC-mediated vasculitis. IC-mediated
vasculitis is a disease initiated by the deposition of antigen-
antibody complexes in dermal blood vessels, which subse-
quently lead to complement activation, neutrophil recruit-
ment and activation. The large amount of ROS and proteases
released from activated neutrophils damage the endothelial
lining of the vessel wall and result in edema and hemorrhage
[25, 26]. In skin tissue, sections derived from six patients suf-
fering from IC-mediated vasculitis, damaged blood vessels
contained fibrin deposit and infiltrated neutrophils in the ves-
sel wall (Fig. 3A, 3B, 3E) as well as extravasated red blood
cells within the interstitial connective tissue of the skin.
Importantly, NET structures (Fig. 3C) and the expression of NE
and MPO (Fig. 3D–3F) were detected in skin sections derived
from vasculitis patients, whereas none of these components
were discernable in normal skin (Fig. 3C–3F).
To further explore the effect of MSCs on preventing the
observed vessel damage by activated neutrophils, we
employed a mouse model of IC-mediated vasculitis, in which
mice were challenged with an Arthus reaction. For this pur-
pose i.v. injection of a solution containing 2% BSA and 1%
Evans blue dye was performed and an anti-BSA antibody was
Figure 3. Activated neutrophils mediated tissue damage in vasculitis patients. (A–D): Representative microphotographs of paraffin-
embedded skin sections from six healthy donor (left panel) and six vasculitis patients (right panel) with H&E staining (A–B), immuno-
staining of human neutrophil marker CD15 (green) and neutrophil extracellular traps marker DNA/Histone-1 (red) (C), and immunostain-
ing of NE (green) and MPO (red) (D). In immunostainings nuclei were counterstained with DAPI (blue). The squares in (A) indicate the
enlarged areas in (B). White arrows indicate blood vessels, black arrows indicate neutrophils in (B). Scale bar: 50 mm. (E–F): The percent-
age of CD151 neutrophils and NE1 MPO1 neutrophils was calculated from each skin section of 6 different healthy donors and 6
patients with vasculitis and expressed as mean6 SEM of CD151 neutrophils (E) and NE1 MPO1 neutrophils (F). n5 6; **, p< .01 by
Mann–Whitney tests. Abbreviations: MPO, myeloperoxidase; NE, neutrophil elastase.
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intradermally injected to the skin area that previously had
received either MSCs or PBS injection. After 4 hours, mice
were sacrificed and skin specimen were harvested and digi-
tally photographed to quantify the extent of Evans blue-
marked vascular leakage (Fig. 4A). Such areas, indicative of
the extent of vessel damage due to BSA/anti-BSA complex
formation, were analyzed by Image J software (Fig. 4B). Intra-
dermal injection of MSCs resulted in significantly reduced
areas of Evans blue staining by 52.1% compared to PBS con-
trol (15.8 vs. 33.0 AU, n5 10) (Fig. 4C). Moreover, the dermis
of the mice subjected to Arthus reaction with PBS injection
showed severe damage of vessels surrounded by red blood
Figure 4. MSCs reduce vessel destruction and hemorrhage in immune complex-mediated vasculitis. (A): 100 ml PBS or 2.5 x 105 AT-
MSCs were intradermally injected to both sides of shaved dorsal skin of mice. The Arthus reaction was elicited by i.v. injection of 100 ml
PBS solution containing 2% BSA and 1% Evans blue. Afterward anti-BSA antibody was intradermally injected to the area that had been
injected with AT-MSCs or PBS. Four hours later, mice were sacrificed and skin specimen were harvested and digitally photographed. (B–
C): The areas of Evans blue spots on skin were analyzed by Image J. n5 10; **, p< .01 by Mann-Whitney tests. (D–T): Mice were intra-
dermally injected with PBS or nontransfected MSCs or SOD3-siRNA transfected MSCs or control-siRNA transfected MSCs and subjected
to Arthus reaction. Mice received rabbit IgG served as healthy controls. Representative pictures of paraffin-embedded skin sections
from 4 mice of each group with H&E staining (D, G, J, M, P), immunostaining of murine neutrophil marker Ly6G (green) and NETs
marker DNA/Histone-1 (red) (E, H, K, N, Q), and immunostaining of NE (green) and MPO (red) (F, I, L, O, R) are shown. Nuclei were
counterstained with DAPI (blue) in immunostainings. White arrows in H&E staining indicate blood vessels. Scale bar: 50 mm. (S–T) The
depicted are mean6 SEM of Ly6G1 cells (S) and NE1 MPO1 cells (T) counted from each section of 4 mice. n5 4; *, p< .05; **, p< .01
by Mann-Whitney tests. Abbreviations: AU, arbitrary unit; MSCs, mesenchymal stem cells; MPO, myeloperoxidase; NE, neutrophil
elastase.
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cells and neutrophils (Fig. 4G, 4S) with NETs (Fig. 4H), NE and
MPO in the tissue (Fig. 4I, 4T), which very much resemble the
features of human vasculitis. In contrast, intradermal injection
of MSCs protected vessel structure (Fig. 4J, 4S) with signifi-
cantly reduced NETs (Fig. 4K) and reduced numbers of NE1
MPO1 neutrophils in the dermis (Fig. 4L, 4T), which were sim-
ilar to skin specimen from healthy control mice (Fig. 4D–4F).
MSCs Protect Tissue Damage by Enhanced SOD3
Release upon Neutrophil Activation
To search for the protective, possibly anti-oxidant mechanism
of MSCs, the expression of anti-oxidant genes NRF2, SOD1,
SOD2, and SOD3 was quantified by qPCR in MSCs that had
been cocultured with PMA-activated mNeu or treated with
same concentration of PMA alone. No significant differences
in specific mRNA levels for these genes were found in the
first 24 hours (Supporting Information Fig. S4A–S4D). How-
ever, using an SOD3 ELISA we corroborate and extend previ-
ous findings [36, 37] that MSCs constitutively release SOD3, a
soluble extracellular form of superoxide dismutase, which can
detoxify the superoxide anion radical in their proximate
microenvironment [36]. Interestingly and previously unre-
ported, we found that the release of SOD3 was markedly
increased when MSCs were cocultured with PMA-activated
mNeu as early as 2 hours of coculture (Fig. 5A), and at a sig-
nificantly higher extent after 24 hours of coculture (Fig. 5B).
The induction of SOD3 release could be due to ROS released
by activated neutrophils, since both hydrogen peroxide (H2O2)
and hypoxanthine/xanthine oxidase generated superoxide
anion (O22 ) induced SOD3 release from MSCs in vitro (Sup-
porting Information Fig. S5A, S5B). Moreover, MSCs were
found to release SOD3 in vivo following intradermal injection
into the skin of mice suffering from IC-mediated vasculitis
(Fig. 5C). These data indicate that MSCs adaptively respond to
the oxidative microenvironment by actively releasing SOD3. To
investigate whether SOD3 is also upregulated in their endoge-
nous niche in human vasculitis and a murine model of vasculi-
tis, we took advantage of the only single marker ABCB5, a
transporter protein at the cell membrane which specifically
allows to detect a newly identified dermal MSC subpopulation
within the skin in situ [38]. We found that, as is the case with
adipose tissue derived MSCs, ABCB51 MSCs exerted similar
suppressive effects on ROS release (Supporting Information
Fig. S6A) and NET formation (Supporting Information Fig. S6B,
S6C) from activated hNeu, both key features of MSC-based
prevention and treatment of IC-mediated vasculitis. Of note,
immunostaining for ABCB5 and SOD3 revealed a significantly
higher frequency of double positive MSCs in human and
murine IC-mediated vasculitis (Fig. 5D) compared to healthy
controls (Fig. 5E, 5F). These data indicate that MSCs mount an
adaptive antioxidant SOD3 response in their endogenous
niche to protect themselves from the threat of neutrophil oxi-
dative burst. However, opposed to the tissue protecting effect
of therapeutically injected MSCs at high numbers, endogenous
MSCs at physiological low numbers of 0.2% of total dermal
cells are unable to protect from vasculitis and tissue break
down.
To investigate whether SOD3 is responsible for the ROS-
reducing and tissue protecting effects of injected MSCs at
high numbers, SOD3 mRNA, but not SOD2 or SOD1 mRNAs,
was silenced in MSCs by two independent SOD3 siRNAs
selected from four tested ones (Supporting Information Fig.
S5C–S5F). The capacity of SOD3-silenced MSCs to suppress
the PMA-induced oxidative burst of mNeu in vitro was sub-
stantially reduced compared to control siRNA-transfected
MSCs (Fig. 5G, 5H). Of note, SOD3-silenced MSCs significantly
lost the capacity to reduce hemorrhage in IC-mediated vascu-
litis mouse model compared to control-siRNA transfected
MSCs (Fig. 5I, 5J). In support of these findings, immunostain-
ing of skin specimen derived from mice subjected to IC-
mediated vasculitis and intradermal injection of SOD3-silenced
MSCs showed severe damage of vessels surrounded by Ly6G1
neutrophils (Fig. 4M, 4S) with increased NETs structures (Fig.
4N), enhanced MPO and NE expression (Fig. 4O, 4T) in the
affected tissue. In contrast, results with control-siRNA-
transfected MSCs (Fig. 4P–4R) or non-transfected MSCs (Fig.
4J–4L) revealed a tissue-protective outcome, indicative for
SOD3 being responsible for the suppressive effect of MSCs on
neutrophil-mediated tissue damage.
DISCUSSION
We here characterized versatile skills of MSCs to adaptively
respond to changes in their microenvironment and to employ
a previously unreported combination of tissue-protective
strategies to combat overactivated neutrophils and their toxic
content. Based on the adaptive induction of antioxidant
enzymes, particularly SOD3, MSCs are able to efficiently
dampen the oxidative burst outcome of neutrophils, to sup-
press their release of destructive enzymes such as peroxidases
and proteases and to inhibit NET formation. In addition, we
uncovered the previously unreported ICAM-1-dependent
increase in uptake and engulfment of apoptotic neutrophils
by MSCs to avoid spillage of their toxic cargo. Together, with
this multitalented capacity of protective functions, MSCs take
a major part in the regulation of tissue homeostasis/inflam-
mation in order to balance the outcome of pathogen defense
and niche protection. Our in vitro and in vivo data with par-
ticular emphasis on skin tissue not only provide unprece-
dented insights into self-regulatory mechanisms in innate
immunity but also hold substantial promise to develop novel
MSC-based strategies for the treatment of disorders with
unlimited neutrophil activation, associated with tissue dam-
age. The here identified mechanisms which in their combina-
tion allow MSCs to effectively suppress unrestrained
neutrophil activation by complementary environmentally
adaptive responses (Fig. 6) can be dissected as follows:
First, PMA-induced neutrophil activation with enhanced
generation of ROS was alleviated in vitro in cocultures of neu-
trophils and MSCs as well as following MSC injection in the
PMA-induced neutrophilic dermatitis in vivo. Since neither
enhanced ROS-release nor neutrophil recruitment occurred in
CD18-deficient mice, overactivation of neutrophils was
responsible for the elevated O22 -liberation. Second, neutro-
phil degranulation with the release of MPO, MMP-9 and elas-
tase was suppressed in the presence of MSCs in vitro and in
a murine IC-mediated vasculitis model in vivo. Here, the
expulsion of nuclear chromatin as NETs was significantly sup-
pressed following injection of MSCs. Since the histone compo-
nents of NETs confer significant cytotoxicity [32], this self-
destructing activity of NETs can equally be reduced by MSCs.
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Figure 5. Induced SOD3 from MSCs is responsible for neutrophil suppressive effects. (A–B): 2 x 105 AT-MSCs were cultured alone or
with 2 x 106 mNeu activated by 100 ng/ml PMA. mNeu treated with DMSO served as nonactivated controls. AT-MSCs treated with 100
ng/ml PMA served as control for PMA effects. Supernatants were harvested 2 hours (A) and 24 hours (B) after onset of coculture, and
SOD3 concentrations in supernatants were measured by ELISA. This experiment was independently performed three times with similar
results. (C): 2.5 x 105 AT-MSCs were intradermally injected to shaved dorsal skin of mice. The Arthus reaction was elicited by i.v. injec-
tion of 100 ml of 2% BSA in PBS and intradermal injection of anti-BSA antibody to the area that had been injected with AT-MSCs. 4
hours later, mice were sacrificed and skin specimen were processed for cryosections. Sections were immunostained with human specific
beta-2 microglobulin (b2M, green, indicative of MSCs) and SOD3 (red), and nuclei were counterstained with DAPI (blue). The square in
the left panel indicates the area enlarged in the right panel. White scale bar: 100 mm; yellow scale bar: 20 mm. (D–F): Endogenous
ABCB51 dermal MSCs express SOD3 in situ. Depicted in (D) are representative microphotographs of paraffin-embedded skin sections
from human vasculitis patients with immunostaining of human ABCB5 (green) and human SOD3 (red) (left panel), and mice subjected
to IC-mediated vasculitis with immunostaining of ABCB5 (green) and murine SOD3 (red) (right panel), respectively. Scale bar: 10 mm.
The percentage of ABCB51 SOD31 cells in total dermal cells in each section are expressed as mean6 SEM in human (E) and murine (F)
samples, respectively. n 5 8; **, p< .01 by Student’s t tests. (G–H): 2 3 106 mNeu were cultured alone or with non-transfected MSCs
or control-siRNA transfected MSCs, or SOD3-silenced MSCs at a mNeu:MSC ratio of 10:1, and subjected to PMA-induced oxidative burst
assay with reactive oxygen species indicator dihydrorhodamine 123. The depicted histograms in (G) are representative of three inde-
pendent experiments. The mean fluorescence intensity (MFI) of each sample in (G) was normalized to MFI of PMA activated neutrophils
as percentages in the same experiment. The chart depicted in (H) is mean6 SEM of percentage of MFI derived from three experiments.
**, p< .01; ***, p< .001 by Student’s t tests. (I–J): 100 ml PBS or 2.5 3 105 control-siRNA transfected MSCs or SOD3-silenced MSCs
were intradermally injected into dorsal skin of mice. The Arthus reaction was elicited at the areas that had been injected with MSCs or
PBS. Four hours later, mice were sacrificed and skin specimen were harvested and digitally photographed. The areas of Evans blue on
skin specimen with MSCs treatment were normalized to Evans blue stained areas after PBS injection on the same mouse and expressed
as percentages. n5 8; **, p< .01; ***, p< .001 by Mann–Whitney tests. Abbreviations: MSCs, mesenchymal stem cells; mNeu, murine
bone marrow neutrophils; SOD3, superoxide dismutase 3.
Third, MSCs were found to engulf overactivated neutrophils
and thus effectively suppress further tissue damage due to
prevention of ROS-release, NET formation and the spillage of
tissue-toxic proteases. Of note, the b2-integrin ligand, ICAM-
1, which is upregulated on MSCs during inflammation [39],
was identified to be indispensable for neutrophil engulfment.
Fourth, MSCs were herein shown to mount an adaptive
response upon exposure to high O22 concentrations and
derivatives thereof. In particular, the adaptive upregulation of
SOD3 via its O22 -dismutating activity may effectively reduce
the highly toxic high O22 levels, and hence prevents the pro-
duction of peroxynitrite as well as hydroxyl radicals.
The contention that SOD3 represents an effective strategy
of MSCs to reduce unrestrained neutrophil activation was
clearly supported by the fact that ablation of SOD3 in MSCs
by RNAi virtually abrogated the tissue-preserving functions of
MSCs as shown in the murine IC-mediated vasculitis model.
These findings are of clinical relevance, as they convincingly
show that MSCs make use of different complementing strat-
egies to reduce overall tissue damage. The notion that the
used murine model is particularly suited to recapitulate
human vasculitis with unrestrained neutrophil activation is
further supported by the finding that—similar to our observa-
tions in the murine model—unlimited NET formation,
enhanced release of MPO and NE and severe tissue damage
also occurred in human IC-mediated vasculitis. Our data thus
provide better mechanistic insights into the spectrum of
human disorders with neutrophil overactivation that are cur-
rently difficult-to-treat and that reveal high morbidity and
mortality. The disease entities with unrestrained neutrophil
activation include microscopic polyangiitis, lupus erythemato-
sus (both characterized by IC-mediated vasculitis with severe
kidney, skin and lung damage), pyoderma gangrenosum, or
genetic deficiencies of the IL-1- or IL-36-receptor antagonist
Figure 5. Continued.
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with severe skin, bone and joint destruction [2, 4]. Neutro-
phils from lupus patients often suffering from IC-mediated
vasculitis are found to have enhanced capacity to form NETs,
which is associated with increased anti-dsDNA antibodies in
sera of lupus patients [40]. Affected skin and kidneys from lupus
patients are infiltrated by netting neutrophils, which cause
endothelial cell damage, a critical step in the pathogenesis of
lupus and other neutrophil overactivation syndromes [41].
Excessive release of proteases from neutrophils, such as NE
and MMP-9, leads to excessive extracellular matrix (ECM) degra-
dation and tissue damage and plays a role in several degenera-
tive and inflammatory diseases [42, 43]. Our finding that MSCs
rescue neutrophils from cell death and thus prevent NETosis
and/or spillage of their toxic proteolytic cargo either decorated
on expulsed chromatin or simply released to their surrounding
is of major importance to limit and resolve unrestrained inflam-
mation in the interest of organ preservation. A recent study has
shown that in patients with severe carotid stenosis, statin treat-
ment reduces neutrophil infiltration and activity with reduced
serum levels of MMP-9, MPO and NE, and in consequence cor-
relates with reduced cardiovascular risk [44]. Similarly, in
rodents, the elastase inhibitor reduces NE activity and subse-
quently reduces inflammation and fibrosis after murine myocar-
ditis [45], reduces liver damage due to ischemia and
reperfusion injury [46], and diminishes neurologic symptoms
after spinal cord injury as well [47].
As opposed to previously published data that human
MSCs of different tissue origin constitutively release low level
SOD3 [36, 37, 48, 49], we here advance our understanding
that MSCs—upon exposure to elevated O22 levels originating
from neutrophil oxidative burst—mount an adaptive response
with increased SOD3 expression in their endogenous niche in
murine and human vasculitis in vivo. Stimulated by this
unprecedented observation that MSCs of the endogenous
niche mount an antioxidant response with SOD3 overexpres-
sion, which most likely preserves the integrity of endogenous
MSCs but is not able to suppress overall tissue damage in
neutrophil induced vasculitis, we have used therapeutic injec-
tions of MSCs. In support of this notion, we provide causal in
vivo evidence that NET formation and the release of highly
toxic ROS and proteases from neutrophils are effectively
counteracted by enhanced SOD3 release from MSCs thus pre-
serving tissue integrity. These data imply that the oxidative
burst of neutrophils, in fact, cause NET formation and the
release of the tissue toxic cargo from neutrophils. Independ-
ent of the SOD3 defense, neutrophils are actively engulfed by
MSCs as an additional tissue protecting strategy. Hence, MSCs
have evolved multilayered strategies to counteract and pro-
tect from overactivated neutrophils in the interest of tissue
integrity.
SOD3 represents the only antioxidant enzyme that scav-
enges O22 in the extracellular compartment. SOD3 addition-
ally competes with nitric oxide and H2O2 for O
2
2 , thereby
reducing the production of peroxynitrite and hydroxyl radical,
respectively. Peroxynitrite and hydroxyl radicals constitute the
most prevailing reactive radicals and major effectors of tissue
injury [50]. SOD3 released from MSCs exerts protective effects
on cardiomyocytes [49], cerebellar neurons [37] and lung
remodelling [48]. Besides its antioxidant effect, SOD3 has the
capacity to activate the Ras-MAPK pathway to induce prolifer-
ation and metabolic functions of injured tissue [51], and to
diminish apoptosis through phosphorylation of Erk1/2, Akt
and FoxO3a [52]. By its ability to regulate expression of adhe-
sion molecules and cytokines [53], SOD3 is able to reduce
inflammatory cell migration as well.
As to the question of how elevated O22 levels result in an
adaptive MSC response of increased SOD3 release, several
possibilities may exist. First, oxidized extracellular DNA and
oxidized cell-free GC-rich ribosomal DNA—available in excess
at the site of neutrophil activation—can trigger enhanced
SOD3-release via the TLR9- and NFjB-dependent signaling
pathways [54, 55]. Second, enhanced O22 -dismutation with
increased H2O2 generation also may stimulate SOD3-release in
a NFjB dependent manner [56]. Third, H2O2 stimulates SODs
through p38 MAPK [57] and PI3K/Akt signaling [56]. Fourth,
SOD3 released from MSCs can be induced by inflammatory
cytokines such as TNF-a and IFN-g [36] occurring in
neutrophil-initiated inflammation. Other antioxidant response
genes like NRF2, KEAP1, SOD1, BRCA1, and BCL2 involved in
self-defense are also reported to be upregulated in MSCs in
oxidative stress-induced conditions [54]. Though no change in
the specific mRNA levels for NRF2 and other above men-
tioned antioxidant enzymes were detected in MSCs cocultured
with activated neutrophils, we observed the translocation of
NRF2 from the cytoplasm to the nucleus, indicative of NRF2
activation, in MSCs 24 hours after coculturing with activated
neutrophils (Supporting Information Fig. S4E). It is tempting
to speculate that activation of NRF2 upregulates SOD3 expres-
sion for the long term response, since SOD3 but not SOD1 or
Figure 6. Scheme of adaptive MSC responses to unrestrained
neutrophil activation. Immune complexes inside and outside the
vessel lead to unrestrained neutrophil activation with enhanced
generation and release of O22 which can stimulate NET formation
with expulsion of chromatin decorated with granules and highly
concentrated MPO, NE and MMP-9, neutrophil death with spill-
age of their toxic cargo leading to tissue damage and tissue break
down. Further damage to macromolecules occur by O22 and
derivatives thereof like H2O2, ONNO
. and hydroxyl radicals (HO.).
MSCs are able to mount an adaptive response to unrestrained
neutrophil activation, with the release of O22 detoxifying extrac-
ellular SOD3 and ICAM-1/CD18 dependent engulfment of dying
neutrophils thus preventing the spillage of their toxic cargo. By
employing independent strategies MSCs effectively protect from
tissue damage due to unrestrained neutrophil activation. Abbrevi-
ations: ICAM-1, intercellular adhesion molecule 1; H2O2, hydrogen
peroxide; MMP-9, matrix metalloproteinase-9; MPO, myeloperoxi-
dase; MSCs, mesenchymal stem cells; NE, neutrophil elastase;
NET, neutrophil extracellular trap; ONNO., peroxynitrate; SOD3,
superoxide dismutase 3.
2404 MSCs Suppress Neutrophil-Mediated Tissue Damage
VC AlphaMed Press 2016 STEM CELLS
SOD2 is reported to be regulated through NRF2 [58]. There-
fore, together with our data of SOD3-silenced MSCs,
enhanced SOD3 release from MSCs represents a major tissue
protective strategy counteracting microenvironmental oxida-
tive stress during unbalanced inflammation.
We, however, cannot exclude that in addition to SOD3 other
mechanisms may contribute to counteract tissue damage and
injury due to unrestrained neutrophil activation. In fact, we and
others have earlier shown that MSCs dampen inflammation and
in consequence reduce scar formation in tissue repair via the
release of tumor necrosis factor-inducible gene 6 protein (TSG-
6) [21, 59]. MSCs-derived TSG-6 has been shown to bind to IL-8
directly and inhibit neutrophil migration [60]. At least, extrava-
sation, activation and infiltration of neutrophils into the joint
synovium were increased in a murine TSG-6 deficient model of
rheumatoid arthritis, also displaying an increase in plasmin,
MPO and NE release from neutrophils [61].
CONCLUSION
In summary, we identified a multilayered strategy of mesen-
chymal stem cells to suppress tissue damage due to overacti-
vated neutrophils. Protective strategies included ICAM-1
mediated engulfment of neutrophils and an adaptive release
of SOD3 dampening enhanced ROS level and in consequence
suppress NET formation, neutrophil death and excessive spill-
age of proteases. Our data provide insight into MSC-mediated
protective functions in the context of innate immunity and
thus holds substantial promise to therapeutically counteract
states of neutrophil overactivation.
ACKNOWLEDGMENTS
We thank Carmen Hauser (The Institute for Laser Technology
in Medicine and Measurement Technique, University of Ulm)
for technical support of confocal microscopy, and Alexander
Magnutzki (Institute of Physiological Chemistry, University of
Ulm) for technical support for in vivo imaging system. This
study was supported in part by research grants from the
Baden-W€urttemberg Stiftung (P-BWS-ASII/15), the European
Commission (CASCADE HEALTH-FP7-223236) and the German
Research Foundation (SFB1149) to K.S.-K., the Baustein Pro-
gram from the Medical Faculty, University of Ulm (LSBN.0100)
to D.J., and from the Excellence Cluster Cardio-pulmonary Sys-
tem (ECCPS) to M.S. and K.T.P.
AUTHOR CONTRIBUTIONS
D.J.: Conception and design, Collection and/or assembly of
data, Data analysis and interpretation, Manuscript writing;
J.M.: Collection and/or assembly of data; Y.Q.: Collection and/
or assembly of data; A.K.: Collection and/or assembly of data;
J.C.V: Collection and/or assembly of data; M.S.: Collection
and/or assembly of data, Data analysis and interpretation;
A.S. and S.V.B.: Conception and design, Data analysis and
interpretation; M.W.: Administrative support, Final approval of
manuscript; A.M.K. and C.G.: Provision of study material or
patients, Final approval of manuscript; N.Y.F. and M.H.F.: Data
analysis and interpretation, Final approval of manuscript;
K.T.P.: Conception and design, Financial support, Final approval
of manuscript; K.S.-K.: Conception and design, Financial sup-
port, Data analysis and interpretation, Manuscript writing.
DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST
M.H.F. and N.Y.F. are inventors or co-inventor of US and inter-
national patents assigned to Brigham and Women’s Hospital
and/or Boston Children’s Hospital, Boston, MA, and licensed
to Ticeba GmbH (Heidelberg, Germany) and Rheacell GmbH &
Co. KG (Heidelberg, Germany). M.H.F. serves as a scientific
advisor to Ticeba GmbH and Rheacell GmbH & Co. KG. and
participates in corporate sponsored research collaborations
with Rheacell GmbH & Co. KG.
REFERENCES
1 Leto TL, Geiszt M. Role of Nox family
NADPH oxidases in host defense. Antioxid
Redox Signal 2006;8:1549–1561.
2 Mocsai A. Diverse novel functions of
neutrophils in immunity, inflammation, and
beyond. J Exp Med 2013;210:1283–1299.
3 Rayment EA, Upton Z, Shooter GK.
Increased matrix metalloproteinase-9 (MMP-
9) activity observed in chronic wound fluid is
related to the clinical severity of the ulcer. Br
J Dermatol 2008;158:951–961.
4 Amulic B, Cazalet C, Hayes GL et al.
Neutrophil function: from mechanisms to dis-
ease. Annu Rev Immunol 2012;30:459–489.
5 Brinkmann V, Reichard U, Goosmann C
et al. Neutrophil extracellular traps kill bacte-
ria. Science 2004;303:1532–1535.
6 Cohen PR. Neutrophilic dermatoses: A
review of current treatment options. Am J
Clin Dermatol 2009;10:301–312.
7 Coxon A, Cullere X, Knight S et al. Fc
gamma RIII mediates neutrophil recruitment
to immune complexes. A mechanism for neu-
trophil accumulation in immune-mediated
inflammation. Immunity 2001;14:693–704.
8 Kahlenberg JM, Carmona-Rivera C, Smith
CK et al. Neutrophil extracellular trap-
associated protein activation of the NLRP3
inflammasome is enhanced in lupus macro-
phages. J Immunol 2013;190:1217–1226.
9 McDaniel JC, Roy S, Wilgus TA. Neutro-
phil activity in chronic venous leg ulcers–a
target for therapy? Wound Repair Regen
2013;21:339–351.
10 Hussain SP, Hofseth LJ, Harris CC. Radi-
cal causes of cancer. Nat Rev Cancer 2003;3:
276–285.
11 Stappenbeck TS, Miyoshi H. The role of
stromal stem cells in tissue regeneration and
wound repair. Science 2009;324:1666–1669.
12 Akiyama K, Chen C, Wang D et al. Mes-
enchymal-stem-cell-induced immunoregula-
tion involves FAS-ligand-/FAS-mediated T cell
apoptosis. Cell Stem Cell 2012;10:544–555.
13 Ren G, Zhang L, Zhao X et al. Mesenchy-
mal stem cell-mediated immunosuppression
occurs via concerted action of chemokines
and nitric oxide. Cell Stem Cell 2008;2:141–
150.
14 Kavanagh H, Mahon BP. Allogeneic mes-
enchymal stem cells prevent allergic airway
inflammation by inducing murine regulatory
T cells. Allergy 2011;66:523–531.
15 Selmani Z, Naji A, Zidi I et al. Human
leukocyte antigen-G5 secretion by human
mesenchymal stem cells is required to sup-
press T lymphocyte and natural killer func-
tion and to induce CD41CD25highFOXP31
regulatory T cells. STEM CELLS 2008;26:212–
222.
16 Corcione A, Benvenuto F, Ferretti E
et al. Human mesenchymal stem cells modu-
late B-cell functions. Blood 2006;107:367–
372.
17 Nauta AJ, Kruisselbrink AB, Lurvink E
et al. Mesenchymal stem cells inhibit genera-
tion and function of both CD341-derived
and monocyte-derived dendritic cells.
J Immunol 2006;177:2080–2087.
18 Sotiropoulou PA, Perez SA, Gritzapis AD
et al. Interactions between human mesen-
chymal stem cells and natural killer cells.
STEM CELLS 2006;24:74–85.
19 Dayan V, Yannarelli G, Billia F et al. Mes-
enchymal stromal cells mediate a switch to
alternatively activated monocytes/macro-
Jiang, Muschhammer, Qi et al. 2405
www.StemCells.com VC AlphaMed Press 2016
phages after acute myocardial infarction.
Basic Res Cardiol 2011;106:1299–1310.
20 Jiang D, Qi Y, Walker NG et al. The effect
of adipose tissue derived MSCs delivered by
a chemically defined carrier on full-thickness
cutaneous wound healing. Biomaterials 2013;
34:2501–2515.
21 Qi Y, Jiang D, Sindrilaru A et al. TSG-6
released from intradermally injected mesen-
chymal stem cells accelerates wound healing
and reduces tissue fibrosis in murine Full-
thickness skin Wounds. J Invest Dermatol
2014;134:526–537.
22 Raffaghello L, Bianchi G, Bertolotto M
et al. Human mesenchymal stem cells inhibit
neutrophil apoptosis: A model for neutrophil
preservation in the bone marrow niche. STEM
CELLS 2008;26:151–162.
23 Teo GS, Yang Z, Carman CV et al. Intravi-
tal imaging of mesenchymal stem cell traf-
ficking and association with platelets and
neutrophils. STEM CELLS 2015;33:265–277.
24 Chung TN, Kim JH, Choi BY et al. Adi-
pose-derived mesenchymal stem cells reduce
neuronal death after transient global cerebral
ischemia through prevention of blood-brain
barrier disruption and endothelial damage.
Stem Cells Transl Med 2015;4:178–185.
25 Feld M, Goerge T, Hillgruber C et al.
alpha-1-Antitrypsin and IFN-gamma reduce
the severity of IC-mediated vasculitis by reg-
ulation of leukocyte recruitment in vivo.
J Invest Dermatol 2012;132:2286–2295.
26 Sindrilaru A, Seeliger S, Ehrchen JM
et al. Site of blood vessel damage and rele-
vance of CD18 in a murine model of immune
complex-mediated vasculitis. J Invest Derma-
tol 2007;127:447–454.
27 Lundqvist-Gustafsson H, Bengtsson T.
Activation of the granule pool of the NADPH
oxidase accelerates apoptosis in human neu-
trophils. J Leukoc Biol 1999;65:196–204.
28 Fretland DJ, Gokhale R, Mathur L et al.
Dermal inflammation in primates, mice, and
guinea pigs: attenuation by second-generation
leukotriene B4 receptor antagonist, SC-53228.
Inflammation 1995;19:333–346.
29 Kielland A, Blom T, Nandakumar KS
et al. In vivo imaging of reactive oxygen and
nitrogen species in inflammation using the
luminescent probe L-012. Free Radic Biol
Med 2009;47:760–766.
30 Peters T, Sindrilaru A, Hinz B et al.
Wound-healing defect of CD18(-/-) mice due
to a decrease in TGF-beta1 and myofibroblast
differentiation. Embo J 2005;24:3400–3410.
31 Prokopowicz Z, Marcinkiewicz J, Katz DR
et al. Neutrophil myeloperoxidase: Soldier
and statesman. Arch Immunol Ther Exp
(Warsz) 2012;60:43–54.
32 Saffarzadeh M, Juenemann C, Queisser
MA et al. Neutrophil extracellular traps
directly induce epithelial and endothelial cell
death: a predominant role of histones. PLoS
One 2012;7:e32366.
33 Bruns S, Kniemeyer O, Hasenberg M
et al. Production of extracellular traps against
Aspergillus fumigatus in vitro and in infected
lung tissue is dependent on invading neutro-
phils and influenced by hydrophobin RodA.
PLoS Pathog 2010;6:e1000873.
34 Yost CC, Cody MJ, Harris ES et al. Impaired
neutrophil extracellular trap (NET) formation: A
novel innate immune deficiency of human neo-
nates. Blood 2009;113:6419–6427.
35 Williams MA, Solomkin JS. Integrin-
mediated signaling in human neutrophil func-
tioning. J Leukoc Biol 1999;65:725–736.
36 Kemp K, Gray E, Mallam E et al. Inflam-
matory cytokine induced regulation of super-
oxide dismutase 3 expression by human
mesenchymal stem cells. Stem Cell Rev 2010;
6:548–559.
37 Kemp K, Hares K, Mallam E et al. Mes-
enchymal stem cell-secreted superoxide dis-
mutase promotes cerebellar neuronal
survival. J Neurochem 2010;114:1569–1580.
38 Schatton T, Yang J, Kleffel S et al. ABCB5
identifies immunoregulatory dermal Cells.
Cell Rep 2015;12:1564–1574.
39 Ren G, Zhao X, Zhang L et al. Inflamma-
tory cytokine-induced intercellular adhesion
molecule-1 and vascular cell adhesion
molecule-1 in mesenchymal stem cells are
critical for immunosuppression. J Immunol
2010;184:2321–2328.
40 Yu Y, Su K. Neutrophil extracellular traps
and systemic lupus Erythematosus. J Clin Cell
Immunol 2013;4:
41 Villanueva E, Yalavarthi S, Berthier CC
et al. Netting neutrophils induce endothelial
damage, infiltrate tissues, and expose immu-
nostimulatory molecules in systemic lupus
erythematosus. J Immunol 2011;187:538–
552.
42 Lin TC, Li CY, Tsai CS et al. Neutrophil-
mediated secretion and activation of matrix
metalloproteinase-9 during cardiac surgery
with cardiopulmonary bypass. Anesth Analg
2005;100:1554–1560.
43 Sato T, Takahashi S, Mizumoto T et al.
Neutrophil elastase and cancer. Surg Oncol
2006;15:217–222.
44 Lenglet S, Quercioli A, Fabre M et al.
Statin treatment is associated with reduction
in serum levels of receptor activator of NF-
kappaB ligand and neutrophil activation in
patients with severe carotid stenosis. Media-
tors Inflamm 2014;2014:720987.
45 Lee JK, Zaidi SH, Liu P et al. A serine
elastase inhibitor reduces inflammation and
fibrosis and preserves cardiac function after
experimentally-induced murine myocarditis.
Nat Med 1998;4:1383–1391.
46 Uchida Y, Freitas MC, Zhao D et al. The
inhibition of neutrophil elastase ameliorates
mouse liver damage due to ischemia and
reperfusion. Liver Transpl 2009;15:939–947.
47 Tonai T, Shiba K, Taketani Y et al. A neu-
trophil elastase inhibitor (ONO-5046) reduces
neurologic damage after spinal cord injury in
rats. J Neurochem 2001;78:1064–1072.
48 Chow K, Fessel JP, Kaoriihida S et al.
Dysfunctional resident lung mesenchymal
stem cells contribute to pulmonary microvas-
cular remodeling. Pulm Circ 2013;3:31–49.
49 DeSantiago J, Bare DJ, Banach K. Ische-
mia/reperfusion injury protection by mesen-
chymal stem cell derived antioxidant
capacity. Stem Cells Dev 2013;22:2497–2507.
50 Nozik-Grayck E, Suliman HB, Piantadosi
CA. Extracellular superoxide dismutase. Int J
Biochem Cell Biol 2005;37:2466–2471.
51 Laurila JP, Castellone MD, Curcio A et al.
Extracellular superoxide dismutase is a
growth regulatory mediator of tissue injury
recovery. Mol Ther 2009;17:448–454.
52 Laatikainen LE, Incoronato M, Castellone
MD et al. SOD3 decreases ischemic injury
derived apoptosis through phosphorylation
of Erk1/2, Akt, and FoxO3a. PLoS One 2011;
6:e24456.
53 Laurila JP, Laatikainen LE, Castellone MD
et al. SOD3 reduces inflammatory cell migra-
tion by regulating adhesion molecule and
cytokine expression. PLoS One 2009;4:e5786.
54 Loseva P, Kostyuk S, Malinovskaya E
et al. Extracellular DNA oxidation stimulates
activation of NRF2 and reduces the produc-
tion of ROS in human mesenchymal stem
cells. Expert Opin Biol Ther 2012;12(Suppl 1):
S85–S97.
55 Kostjuk S, Loseva P, Chvartatskaya O
et al. Extracellular GC-rich DNA activates
TLR9- and NF-kB-dependent signaling path-
ways in human adipose-derived mesenchy-
mal stem cells (haMSCs). Expert Opin Biol
Ther 2012;12(Suppl 1):S99–111.
56 Rojo AI, Salinas M, Martin D et al. Regu-
lation of Cu/Zn-superoxide dismutase expres-
sion via the phosphatidylinositol 3 kinase/Akt
pathway and nuclear factor-kappaB.
J Neurosci 2004;24:7324–7334.
57 Gutierrez-Uzquiza A, Arechederra M,
Bragado P et al. p38alpha mediates cell survival
in response to oxidative stress via induction of
antioxidant genes: Effect on the p70S6K path-
way. J Biol Chem 2012;287:2632–2642.
58 Singh B, Bhat HK. Superoxide dismutase
3 is induced by antioxidants, inhibits oxida-
tive DNA damage and is associated with inhi-
bition of estrogen-induced breast cancer.
Carcinogenesis 2012;33:2601–2610.
59 Liu S, Jiang L, Li H et al. Mesenchymal
stem cells prevent hypertrophic scar forma-
tion via inflammatory regulation when under-
going apoptosis. J Invest Dermatol 2014;134:
2648–2657.
60 Dyer DP, Thomson JM, Hermant A et al.
TSG-6 inhibits neutrophil migration via direct
interaction with the chemokine CXCL8.
J Immunol 2014;192:2177–2185.
61 Szanto S, Bardos T, Gal I et al. Enhanced
neutrophil extravasation and rapid progres-
sion of proteoglycan-induced arthritis in TSG-
6-knockout mice. Arthritis Rheum 2004;50:
3012–3022.
See www.StemCells.com for supporting information available online.
2406 MSCs Suppress Neutrophil-Mediated Tissue Damage
VC AlphaMed Press 2016 STEM CELLS
